Read + Share
Amedeo Smart
Independent Medical Education
Gauduchon T, Kfoury M, Lorusso D, Floquet A, et al. PARP inhibitors (PARPi) prolongation after local therapy for oligo-metastatic progression in relapsed ovarian cancer patients. Gynecol Oncol 2023;173:98-105.PMID: 37105063
Email
LinkedIn
Facebook
Twitter
Privacy Policy